[Skip to Navigation]
Medical News & Perspectives
April 1, 2020

FDA Trials Find Sunscreen Ingredients in Blood, but Risk Is Uncertain

JAMA. 2020;323(15):1431-1432. doi:10.1001/jama.2020.0792

As head of the Division of Applied Regulatory Science at the US Food and Drug Administration (FDA), David Strauss, MD, PhD, has the unique role of ushering innovative research into the agency’s drug review process. For example, his division’s work includes analyzing drugs’ chemical structure to anticipate rare adverse events, like cancer or liver failure, that often go undetected during clinical trials.

“We take on projects that aren’t being addressed by others in the scientific community,” he said during a recent interview. Unanswered questions surrounding consumer products, like sunscreen, also fall under his purview. Over the past year, his team has published 2 clinical trials in JAMA on sunscreen absorption in the blood.